Patents by Inventor William G. Glass

William G. Glass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING PSORIASIS
    Publication number: 20140079714
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: September 11, 2013
    Publication date: March 20, 2014
    Inventors: Joaquin Mario Valdes, Elliot K. Chartash, William T. Barchuk, Susan K. Paulson, Kenneth B. Gordon, Walid M. Awni, Yanjun Bao, William G. Glass, Yihua Gu, Thomas C. Harris, Martin Kaul, Parvez M. Mulani, Peter A. Noertersheuser, Martin M. Okun
  • Methods for treating psoriasis using antibodies that bind to the P40 subunit of IL-12 and/or IL-23
    Patent number: 8557239
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: October 15, 2013
    Assignees: AbbVie Inc., AbbVie Deutschland GmbH & Co. KG
    Inventors: Joaquin Mario Valdes, Elliot K. Chartash, William T. Barchuk, Susan K. Paulson, Kenneth B. Gordon, Walid M. Awni, Yanjun Bao, William G. Glass, Yihua Gu, Tom C. Harris, Martin Kaul, Parvez M. Mulani, Peter Noertersheuser, Martin M. Okun
  • Method for detecting IL-16 activity and modulation of IL-16 activity based on rantes proxy protein levels
    Patent number: 8067191
    Abstract: Methods for detecting IL-16 biological activity, detecting modulation of IL-16 biological activity, and diagnosing the presence of or susceptibility of a subject to an IL-16-related disorder involve measuring and comparing the levels of RANTES proxy produced by eukaryotic cells, such as CD4+ and CD9+ cell lines, peripheral blood mononuclear cells, HuT-78 cells, and/or THP-1 cells.
    Type: Grant
    Filed: June 6, 2007
    Date of Patent: November 29, 2011
    Assignee: Centocor, Inc.
    Inventor: William G. Glass
  • METHODS FOR TREATING PSORIASIS
    Publication number: 20110206680
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: September 14, 2010
    Publication date: August 25, 2011
    Applicants: ABBOTT LABORATORIES, ABBOTT GMBH & CO., KG
    Inventors: JOAQUIN MARIO VALDES, ELLIOT K. CHARTASH, WILLIAM T. BARCHUK, SUSAN K. PAULSON, KENNETH B. GORDON, WALID M. AWNI, YANJUN BAO, WILLIAM G. GLASS, YIHUA GU, TOM C. HARRIS, MARTIN KAUL, PARVEZ M. MULANI, PETER NOERTERSHEUSER, MARTIN M. OKUM
  • Method for Detecting IL-16 Activity and Modulation of IL-16 Activity Based on Rantes Proxy Levels
    Publication number: 20090325188
    Abstract: Methods for detecting IL-16 biological activity, detecting modulation of IL-16 biological activity, and diagnosing the presence of or susceptibility of a subject to an IL-16-related disorder involve measuring and comparing the levels of RANTES proxy produced by eukaryotic cells, such as CD4+ and CD9+ cell lines, peripheral blood mononuclear cells, HuT-78 cells, and/or THP-1 cells.
    Type: Application
    Filed: June 6, 2007
    Publication date: December 31, 2009
    Inventor: William G. Glass
  • Method for Detecting IL-16 Activity and Modulation of IL-16 Activity Based on Phosphorylated Stat-6 Proxy Levels
    Publication number: 20090130661
    Abstract: Methods for detecting IL-16 biological activity, detecting modulation of IL-16 biological activity, and diagnosing the presence of, or susceptibility to, an IL-16-related disorder in a subject involve measuring and comparing the levels of a phosphorylated STAT-6 proxy produced by eukaryotic cells expressing CD4 or CD9, peripheral blood mononuclear cells, HuT-78 cells, or THP-1 cells.
    Type: Application
    Filed: September 24, 2007
    Publication date: May 21, 2009
    Inventors: William G. Glass, Changbao Liu